At Kineticor, We Bring New Clarity to Imaging

KinetiCor is a medical device company dedicated to improving the quality of imaging.

KinetiCor’s biometric camera captures close-up detailed information in real-time while the patient is undergoing imaging. All motion, even as slight as breathing, is measured accurately. Together with KinetiCor’s patented prospective motion correction technology, we help to address a challenging and costly imaging healthcare problem.

We continue to open up new frontiers in patient monitoring and biometric capture to help enable a new standard in personalized medicine. Heart rate, cardiac and respiratory cycles, without the need for leads or contacts, are the first of many biometric capabilities. This sets the stage for exciting advancements to unlock a new dimension of insight for well-established imaging modalities and techniques.

Management Team

Doug Donzelli – President and CEO

Mr. Donzelli has founded and managed many successful technology ventures over the last 30 years in industries spanning healthcare, medical devices, industrial IoT, education, networking, and application software. Most recently, he served as Founder, Chairman and CEO of Apprion, Inc., an industrial IoT firm, which was sold to the Jacobs Engineering Group in 2017. Prior to Apprion, Mr. Donzelli served as CEO and other executive positions at both private and public companies, including NetManage (“NETM”, “MFGP”) , Novell (“NOVL”), Pensare and Software Transformation. Mr. Donzelli is currently an advisor to Applied Science, Inc., a leading healthcare workflow automation company, and Dragos, Inc., a leading industrial IoT cybersecurity firm.

Jeffrey Yu, M.D. – Chairman/Founder/CTO

Dr. Yu founded KinetiCor to bring motion correction and real-time biometric technologies into the scanner bore to maximize image quality and scanner performance while streamlining workflow and improving efficiency. 

As a radiologist, a key goal of Dr. Yu is to improve imaging safety by reducing or eliminating the need for sedation in children, neonates, and the elderly and reducing dose by reducing repeat scans.

Dr. Yu has board certifications in radiology and nuclear medicine and MR research experience at the Lucas Center at Stanford. He has held multiple executive level positions in health care organizations and startups, most recently as CTO of Queen’s Medical Center, and as Founder & CTO of OneMedNet – a medical image transfer software company.

Michael G. Engelmann, Ph.D. – VP Research & Development

Physicist with 20 years of experience in developing and commercializing sophisticated dual use technologies and medical devices. Dr. Engelmann’s expertise includes software, image sensors, electronic circuit design, mechanical product design, and project management. He was formerly a Senior Scientist at Trex Enterprises, a diversified technology company headquartered in San Diego.

Brad Overby – VP Business Development

Mr. Overby has enjoyed a successful career in healthcare spanning 26 years. Prior to joining KinetiCor, he served in Sales and Marketing leadership positions with PreparedHealth (where he is currently an advisor to the CEO), OneMedNet, Medicity and Professional Healthcare Systems, Inc. In these roles, he built lasting relationships with institutions like Stanford University Hospital, LabCorp, The Queen’s Health Systems in Hawaii, John’s Hopkins University Hospital, Massachusetts General Hospital, and State HIE collaboratives like Colorado Regional Health Information Organization (CORHIO).

Elizabeth Miyagi – VP Finance

Ms. Miyagi has over 30 years of experience in corporate finance, with the last 25 years building finance and operations organizations in startup ventures. Most recently, Ms. Miyagi served as VP Finance at Apprion, Inc., an industrial IoT firm, which was sold to Jacobs Engineering Group in 2017. Previously, Ms. Miyagi held various finance and controller positions at companies such as IBM, Boomerang, and Mockingbird Networks, where she was responsible for the accounting, finance, human resources, budgeting, inventory, and financial system implementations

Leigh-Ann Miyasato – VP Administration & General Counsel

Attorney and executive in Hawai‘i’s entrepreneurial ecosystem for 17 years, most recently as a technology transfer officer at the University of Hawai‘i and as president and founding executive director of the Entrepreneurs Foundation of Hawai‘i.

Advisory Board

Thomas Ernst, Ph.D.

Dr. Ernst is a Professor at the John A. Burns School of Medicine, University of Hawaii, where he is Principal Investigator of a National Institute of Health multi-center program focused on Motion Tracking for Real-Time Adaptive MR Imaging. He obtained his Ph.D. in Physics from the University of Freiburg, Germany, and held faculty positions at UCLA and the Brookhaven National Laboratory (BNL). Dr. Ernst is a Deputy Editor for the Journal of Magnetic Resonance in Medicine, and has been a reviewer for multiple Scientific Journals and Societies.

Oliver Speck, Ph.D.

Dr. Speck is Professor for Biophysics and Director of the Department of Biomedical Magnetic Resonance, Otto-von-Guericke University, Magdeburg, Germany. He obtained his Ph.D. in Physics at the University of Freiburg, Germany, where he also served as Research Director for the Department of Diagnostic Radiology. Dr. Speck is the Deputy Editor for the Magnetic Resonance in Medicine journal.

Thomas Prieto, Ph.D.

Dr. Prieto is a Medical Physicist at Stanford Health Care. He obtained his Ph.D. in Biomedical Engineering at Marquette University and was previously Associate Professor of Neurology at the Medical College of Wisconsin. At Stanford, he provides technical support for the autonomic testing lab and for the deep brain stimulation surgeries for movement disorders. His primary interests are in instrumentation and signal processing methods for the evaluation of autonomic and movement disorders.

Maxim Zaitsev, Ph.D.

Dr. Zaitsev is the Principal Investigator at the Department of Radiology, Medical Physics, University Medical Centre Freiburg, Germany, and the Scientific Director of the Magnetic Resonance Development and Application Center (MRDAC). He obtained his Ph.D. in Physics at the University of Cologne, Germany. Dr. Zaitsev is Deputy Editor for Engineering Systems for the Journal of Magnetic Resonance Imaging and has served as Co-Organizer of the Motion Correction Study Group of the International Society for Magnetic Resonance in Medicine (ISMRM) since 2009.

Robert Herfkens, M.D.

Dr. Robert Herfkens is Professor of Radiology and Associate Chair for Clinical Technology in Radiology at Stanford University. He received his MD degree from Loyola University Stritch School of Medicine. He received residency and fellowship training in Radiology and Nuclear Medicine at University of California San Francisco (UCSF). He is currently director of MRI at Stanford University. His research interests include fundamentals of MR imaging and cardiovascular imaging. He has published over 250 scientific publications. He has served on multiple editorial boards and is past president of the International Society of Magnetic Resonance in Medicine (ISMRM).

Kawin Setsompop, Ph.D

Dr. Setsompop is an Associate Professor in Radiology at Harvard Medical School and an Affiliated Faculty member at Harvard-MIT Division of Health Sciences and Technology (HST). He received his Ph.D. in Electrical Engineering and Computer Science from MIT. Over the last decade, Dr. Setsompop has been a pioneer in the development of a number of MRI acquisition technologies, including parallel transmission and simultaneous multi-slice imaging. In particular, his blipped-CAIPI technology has been distributed to more than 200 research and clinical sites and is now a clinical product on MRI scanners worldwide. Such technology is changing how diffusion, perfusion, and functional MRI are being performed today.

Erkan Akyuz

Mr. Akyuz is the CEO for Rhapsody. He was most recently the EVP & President for McKesson's Imaging, Workflow & Care Solutions. Before taking on this position, he held various executive positions at Canon Medical (formerly Toshiba Medical Systems) and Agfa Healthcare following an extended career as a software developer.

Board of Directors

Jeffrey Yu, M.D. – Chairman

Physician/Entrepreneur with board certifications in radiology and nuclear medicine and MR research experience at the Lucas Center at Stanford. Dr. Yu has held multiple executive level positions in health care organizations and startups, most recently as CTO of Queen’s Medical Center, and as Founder & CTO of OneMedNet – a medical image transfer software company.

Paul Casey – Director

40 years of public and private sector senior management experience across a variety of industries, including airlines, tourism, and software, and in the three major disciplines: finance, revenue, and operations. Mr. Casey has mentored numerous senior executives and is a director of Australian public company, which is focused on intelligent fastening systems.

Henry D.C. Lee – Director

Managing Partner and Founder of Hendale, an Asia-based fund focused on promising growth companies globally with strategic value to the China market. Mr. Lee has over 25 years of experience investing across a wide range of companies and sectors, including healthcare and medical device companies, serving as CIO and Portfolio Manager for large family offices and global asset managers. He is active in the investment communities in Asia, Europe, and the US.

Arthur A. Ushijima – Director

President and CEO of The Queen’s Health Systems, the parent corporation of ten healthcare and real estate companies with an annual operating budget of $1.2 billion, 7,000 employees, and 1,600 physicians. Mr. Ushijima has over 40 years of experience managing and leading hospitals and health systems in five different states.

Barry M. Weinman – Director

Founding partner of Allegis Capital, a $700M venture fund in Silicon Valley, Mr. Weinman has over 30 years of venture capital and over 15 years of operations experience. Examples of top companies: Columbia/HCA (NYSE), Extreme Networks (NASDAQ), PALM (NASDAQ), (NASDAQ), Medscape (NASDAQ).